Skip to main content
Premium Trial:

Request an Annual Quote

Enterome Raises $6.6M in Series A Round

NEW YORK (GenomeWeb News) – Enterome, a privately held biomarker development firm, has raised €5 million ($6.6 million) in a series A round of private funding, it said Thursday.

Paris-based Enterome uses a metagenomic platform to discover biomarkers for metabolic and bowel diseases. The technology was initially developed at France's Institut National de la Recherche Agronomique (INRA), and the firm has exclusive access to discoveries made using the platform in selected human pathologies including type II diabetes, as well as liver and bowel diseases.

Enterome said that it plans to use the funds to validate its proprietary biomarkers and translate them into medical diagnostics, with an eye toward commercializing lab-developed tests in the US and European Union.

The round of financing was co-led by Seventure and Lundbeckfond Ventures. A previous round of financing through Seventure and INRA Transfert, which manages the technology portfolio of INRA, raised €1.5 million.

"The Series A round investors — Seventure and Lundbeckfond Ventures — were specifically attracted to Enterome due to the unique nature of its technology, the close relationship to INRA, and the opportunity to create unique biomarker diagnostic products meeting unmet medical and market needs," Pierre Belichard, CEO of Enterome, said in a statement. "Research by Enterome's scientific founders has improved understanding of the human microbiota composition to the point of now allowing development of powerful new biomarkers and associated therapeutics."

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.